Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Soraya Matczak"'
Autor:
Jérémie F. Cohen, Daniël A. Korevaar, Soraya Matczak, Martin Chalumeau, Slimane Allali, Julie Toubiana
Publikováno v:
Frontiers in Medicine, Vol 7 (2021)
Objectives: Precise international estimates of the age breakdown of COVID-19–related deaths and intensive-care-unit (ICU) admissions are lacking. We evaluated the distribution of COVID-19–related fatalities and ICU admissions by age groups in Eur
Externí odkaz:
https://doaj.org/article/90fe61e4e2b04ced9750ac0be34b9514
Autor:
Christel Chalouhi, Nayla Nicolas, Nancy Vegas, Soraya Matczak, Houmam El Jurdi, Nathalie Boddaert, Véronique Abadie
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
We report 3 cases of scurvy in children that occurred during a short period (2018) in a general pediatrics unit of a tertiary hospital for children in Paris. All children were around 3 years of age and were admitted for skeletal pain and altered gene
Externí odkaz:
https://doaj.org/article/0ed76b7bf35f467691f10faa90f194dc
Autor:
Hervé Lécuyer, Zoé Virion, Jean-Philippe Barnier, Soraya Matczak, Sandrine Bourdoulous, Elsa Bianchini, François Saller, Delphine Borgel, Xavier Nassif, Mathieu Coureuil
Publikováno v:
PLoS Pathogens, Vol 14, Iss 4, p e1006981 (2018)
Purpura fulminans is a deadly complication of Neisseria meningitidis infections due to extensive thrombosis of microvessels. Although a Disseminated Intra-vascular Coagulation syndrome (DIC) is frequently observed during Gram negative sepsis, it is r
Externí odkaz:
https://doaj.org/article/aaf67c9e56c64242be74d32a31eb56b5
Autor:
Pauline Leroux, Soraya Matczak, Bouchez Valérie, Antoine Ouziel, Elise Launay, Albert Faye, Valérie Rabier, Jean Sarlangue, Eric Jeziorski, Zoha Maakaroun-Vermesse, Fouad Madhi, Didier Pinquier, Mathie Lorrot, Marie Pouletty, Aymeric Cantais, Etienne Javouhey, Fatima Aït El Belghiti, Sophie Guillot, Carla Rodrigues, Sylvain Brisse, Jérémie F. Cohen, Julie Toubiana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ae960fee706a658e5b185a820e3fcd
https://doi.org/10.2139/ssrn.4451238
https://doi.org/10.2139/ssrn.4451238
Biological differences between FIM2 and FIM3 fimbriae of Bordetella pertussis: not just the serotype
Autor:
Soraya Matczak, Valérie Bouchez, Pauline Leroux, Thibaut Douché, Nils Collinet, Annie Landier, Quentin Giai Gianetto, Sophie Guillot, Julia Chamot-Rooke, Milena Hasan, Mariette Matondo, Sylvain Brisse, Julie Toubiana
Publikováno v:
Microbes and Infection
Microbes and Infection, 2023, pp.105152. ⟨10.1016/j.micinf.2023.105152⟩
Microbes and Infection, 2023, pp.105152. ⟨10.1016/j.micinf.2023.105152⟩
International audience; Introduction: Bordetella pertussis still circulates worldwide despite vaccination. Fimbriae are components of some acellular pertussis vaccines. Population fluctuations of B. pertussis fimbrial serotypes (FIM2 and FIM3) are ob
Autor:
Soraya Matczak, Corinne Levy, Camille Fortas, Jérémie F Cohen, Stéphane Béchet, Fatima Aït El Belghiti, Sophie Guillot, Sabine Trombert-Paolantoni, Véronique Jacomo, Yann Savitch, Juliette Paireau, Sylvain Brisse, Nicole Guiso, Daniel Lévy-Bruhl, Robert Cohen, Julie Toubiana
Publikováno v:
Eurosurveillance
Eurosurveillance, 2022, 27 (25), pp.2100933. ⟨10.2807/1560-7917.ES.2022.27.25.2100933⟩
Eurosurveillance, 2022, 27 (25), pp.2100933. ⟨10.2807/1560-7917.ES.2022.27.25.2100933⟩
Background Interventions to mitigate the COVID-19 pandemic may impact other respiratory diseases. Aims We aimed to study the course of pertussis in France over an 8-year period including the beginning of the COVID-19 pandemic and its association with
Autor:
Jérémie F. Cohen, Fatima Aït El Belghiti, Juliette Paireau, Camille Fortas, Yann Savitch, Sylvain Brisse, Soraya Matczak, Julie Toubiana, Stéphane Béchet, Nicole Guiso, Robert M. Cohen, Sophie Guillot, Daniel Levy Bruhl, Sabine Trombert, Véronique Jacomo, Corinne Levy
BackgroundInterventions to mitigate coronavirus disease 19 (COVID-19) pandemic may impact other respiratory diseases such as pertussis. We aimed to study the course of pertussis in France over an 8-year period and its association with COVID-19 mitiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d5e9784a02ed33da624bebd2a25f86f
https://doi.org/10.1101/2021.07.16.21260367
https://doi.org/10.1101/2021.07.16.21260367
Autor:
Julie Toubiana, Muhamed-Kheir Taha, Soraya Matczak, Daniel Lévy-Bruhl, Simon Cauchemez, Juliette Paireau, Henrik Salje, Sophie Guillot, Sylvain Brisse, Véronique Jacomo, Fatima Aït El Belghiti, Sabine Trombert-Paolantoni
Publikováno v:
The Lancet. Infectious diseases. 22(2)
Summary Background In April–May, 2013, France modified its pertussis vaccination schedule, which uses the acellular pertussis vaccine, from three primary doses at 2, 3, and 4 months of age and a first booster at 16–18 months of age (former schedu
Autor:
Slimane Allali, Martin Chalumeau, Jérémie F. Cohen, Marianne Leruez, Joséphine Brice, Florence Moulin, Julie Toubiana, Clément Poirault, Fanny Bajolle, Soraya Matczak, Jean-Laurent Casanova, William Curtis, Melissa Taylor
Publikováno v:
Journal of Clinical Immunology
Background An outbreak of multisystem inflammatory syndrome in children, including Kawasaki disease (KD), emerged during COVID-19 pandemic. We explored whether Kawasaki-like disease (KD), when associated with confirmed SARS-CoV-2 infection, has speci
Autor:
Henrik Salje, Sophie Guillot, Daniel Lévy-Bruhl, Julie Toubiana, Sylvain Brisse, Muhamed-Kheir Taha, Soraya Matczak, Sabine Trombert-Paolantoni, Fatima Aït El Belghiti, Véronique Jacomo, Simon Cauchemez, Juliette Paireau
Publikováno v:
The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
The Lancet Infectious Diseases, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2022, 22 (2), pp.265-273. ⟨10.1016/S1473-3099(21)00267-X⟩
Background: In 2013, France modified its pertussis vaccination schedule to remove one dose at 3 months of age and change the age of the booster dose from 16 to 11 months. We aimed to assess the subsequent impact on pertussis epidemiology in France. M